Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Rivoceranib-Based Therapy Improves Outcomes in Recurrent Ovarian Cancer

July 20th 2022

Adding Rivoceranib to pegylated liposomal doxorubicin — a type of chemotherapy — improved survival outcomes for patients with platinum-resistant ovarian cancer, according to recent study results.

To My ‘Cancer Posse,’ Thank You For Everything

July 5th 2022

There are many people in my life who made my cancer experience far easier. I call them my "cancer posse."

Gene Therapy, Gen-1, Shows Promise in Treating Advanced Ovarian Cancer

July 1st 2022

Treatment with Gen-1, a novel gene therapy, resulted in a 33% improvement in progression-free survival for patients with advanced ovarian cancer, according to recent study findings.

FDA Permits the Study of a Novel Cancer Drug for Multiple Solid Tumors to Continue

June 30th 2022

The study the FDA allowed to continue is investigating the safety and efficacy of the novel cancer drug ACR-368 in patients with endometrial, urothelial and ovarian cancer.

Pre- and Post-Surgical Jakafi Plus Chemo Shows Potential in Advanced Ovarian Cancer

June 9th 2022

The use of Jakafi plus chemotherapy shows promise in the pre- and post-surgical treatment settings for patients with stage 3 and 4 ovarian cancer, warranting further study of the combination.

A Behind-the-Scenes Look at My Cancer Clinical Trial Experience

June 1st 2022

It’s good to have all the facts when you decide whether to participate in a cancer drug clinical trial—even the ones that make you swallow hard and tear up.

Investigators Launch Study to Review Novel Cancer Vaccine in Patients With Advanced Solid Tumors

May 26th 2022

A clinical trial just launched to study Vaxinia — a novel cancer vaccine — in patients with previously treated advanced solid tumors.

Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression

May 25th 2022

For patients with advanced epithelial ovarian cancer, there were little — if any — differences in survival outcomes depending on when they received surgery.

'There's a Gift in the Conflict' of Cancer, Says Patrick Dempsey

May 17th 2022

Actor and cancer advocate Patrick Dempsey explains that when a loved one is diagnosed with cancer, it is important that family members make the moments they share together count.

FDA Agrees to Speed Up Review of Ofra-Vec for Platinum-Resistant Ovarian Cancer

April 26th 2022

The FDA granted a Fast Track designation to ofra-vec plus paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

The Return of Spring is a Reminder That the Rough Days of Cancer Will Pass

March 17th 2022

The season of spring represents new awakenings for me, and this year, I’m determined to bring an air of positivity to my life and my cancer experience.

How I Get Through Cancer Survivorship When the Dark Days Take Over

March 8th 2022

While a recent health scare ruined a family vacation, I vowed to keep making plans and always look ahead to brighter days.

New App Aims to Improve the Lives of ‘Core of Our Health Care System’ — Cancer Caregivers

February 28th 2022

When caregivers — considered by many to be an essential part of a patient’s care team — have the tools they need to care for themselves and their loved ones, cancer outcomes can be better, too.

Trametinib Represents a ‘Major Advance’ for Rare Ovarian Cancer Subtype

February 10th 2022

The MEK inhibitor trametinib should be considered a new standard of care for patients with a rare subtype of ovarian cancer, explains an expert from The University of Texas MD Anderson Cancer Center.

My Experience Enrolling in a Cancer Clinical Trial: The Verdict Is ‘Yes’

January 26th 2022

A patient with ovarian cancer describes how she enrolled in a clinical trial, and how it has given her a renewed sense of hope that she may find a successful treatment option.

Louie Anderson Dies After Lymphoma Diagnosis, Tennis Star Chris Evert Shares Ovarian Cancer Diagnosis

January 21st 2022

From the death of comedian Louie Anderson after he was hospitalized for cancer treatment to former world No.1 tennis player Chris Evert’s ovarian cancer diagnosis, here’s what’s happening in the cancer landscape this week.

Regardless of How Many New Year’s Resolutions People Make, A Patient With Cancer Advises Advocating for Oneself

January 5th 2022

After a challenging year due to COVID-19 and rising blood test numbers, a woman living with ovarian cancer shares on what she’s learned and how she’s approaching 2022.

I Regret Not Recognizing My Sister's Ovarian Cancer Symptoms Sooner

December 2nd 2021

A prostate cancer survivor explains his regret over not pushing his sister to visit the doctor as soon as she showed concerning symptoms, which were eventually revealed to be the stage 4 ovarian cancer that took her life.

Frequent Use of Neoadjuvant Chemotherapy May Further Benefit Patients With Advanced Ovarian Cancer

November 30th 2021

Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.

Drug Has ‘Potential to Redefine the Standard of Care’ for Ovarian Cancer Subset

November 30th 2021

Mirvetuximab soravtansine had promising response rates and tolerability in patients with pretreated folate receptor alpha-high platinum-resistant ovarian cancer.

Patient With Cancer Asks, ‘To Port or Not to Port?’

November 16th 2021

A woman with ovarian cancer explains why she was reluctant to get a port put in and why she ultimately went forward with it. “Somehow, I felt that if I got the port, I was giving in to the cancer,” she writes.

The Unknown Path of Cancer: Where to Now?

November 9th 2021

When the road ahead is unclear due to cancer, the best thing you can do is look for a new road to offer hope, a cancer survivor explains.

3 Points: Numbers Have a Different Meaning for Patients With Cancer

October 21st 2021

A woman with ovarian cancer describes how blood work numbers play a key role for patients with cancer and often dictate their thoughts and worries.

Reflecting on Cancer, Life and Death at my 50th High School Class Reunion

October 16th 2021

An ovarian cancer survivor explains how attending her 50th class reunion was an emotional experience as she learned of fellow classmates’ cancer experiences and struggles.

PARP Inhibitors Help Ovarian Cancer Survivors Live Longer – and Better – Without Disease Progression

October 15th 2021

Maintenance therapy with PARP inhibitors may be a beneficial option for patients with ovarian cancer after the first line of treatment.

Patients With Cancer Deserve Respect, Civility and a Voice in Their Treatment

October 6th 2021

Health care isn’t something that is done to you. You participate in it. You’re part of the team. If your team is letting you down, say so. If they don’t do better, consider seeking health care providers who do include you in the conversation.

What Patients With Ovarian Cancer Should Know About Maintenance Therapy

September 29th 2021

Maintenance therapy is meant to prevent relapse after a patient with ovarian cancer received their main treatment. Here’s an overview of what patients should know.

Do I Have Ovarian Cancer? Understanding the Early Signs, Detection and Treatment

September 26th 2021

Learn more about the symptoms, risk factors and treatment options for ovarian cancer.

Age, Other Health Factors Can Play a Role in Cancer Treatment Decisions

September 23rd 2021

The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.

Living With Lynch Syndrome: Pick Your Hard

August 31st 2021

Women with hereditary cancer syndromes must make difficult decisions about whether to keep their reproductive parts and risk dying young, or to remove them but potentially open themselves up to health issues. “Pick your hard,” writes one woman.

NEXT PAGE
PREVIOUS PAGE